The DOI matches its Crossref record; 117 of the 117 references it cites were found in a registry or an index.
Consensus Statement on next-generation-sequencing-based diagnostic testing of hereditary phaeochromocytomas and paragangliomas
Open accessAbstract
As a large number of genes have been implicated in the development of hereditary phaeochromocytomas and paragangliomas (PPGLs), next-generation sequencing (NGS) technology is ideally suited for carrying out genetic screening. This Consensus Statement proposes specific recommendations for the use of diagnostic NGS in hereditary PPGLs. Phaeochromocytomas and paragangliomas (PPGLs) are neural-crest-derived tumours of the sympathetic or parasympathetic nervous system that are often inherited and are genetically heterogeneous. Genetic testing is recommended for patients with these tumours and for family members of patients with hereditary forms of PPGLs. Due to the large number of susceptibility genes implicated in the diagnosis of inherited PPGLs, next-generation sequencing (NGS) technology is ideally suited for carrying out genetic screening of these individuals. This Consensus Statement, formulated by a study group comprised of experts in the field, proposes specific recommendations for the use of diagnostic NGS in hereditary PPGLs. In brief, the study group recommends target gene panels for screening of germ line DNA, technical adaptations to address different modes of disease transmission, orthogonal validation of NGS findings, standardized classification of variant pathogenicity and uniform reporting of the findings. The use of supplementary assays, to aid in the interpretation of the results, and sequencing of tumour DNA, for identification of somatic mutations, is encouraged. In addition, the study group launches an initiative to develop a gene-centric curated database of PPGL variants, with annual re-evaluation of variants of unknown significance by an expert group for purposes of reclassification and clinical guidance.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Richards, S., Aziz, N., Bale, S., Bick, D., Das, S., Gastier-Foster, J., Grody, W. W., Hegde, M., Lyon, E., Spector, E., et al. (2015) · Genetics in Medicine · doi:10.1038/gim.2015.30 · Cited by 32,594
Analysis of protein-coding genetic variation in 60,706 humans
Exome Aggregation Consortium, Lek, M., Karczewski, K. J., Minikel, E. V., Samocha, K. E., Banks, E., Fennell, T., O’Donnell-Luria, A. H., Ware, J. S., Hill, A. J., et al. (2016) · Nature · doi:10.1038/nature19057 · Cited by 9,587
Sequencing technologies – the next generation
Metzker, M. L. (2010) · Nature Reviews Genetics · doi:10.1038/nrg2626 · Cited by 7,066
Comprehensive molecular characterization of clear cell renal cell carcinoma
The Cancer Genome Atlas Research Network (2013) · Nature · doi:10.1038/nature12222 · Cited by 3,485
Pheochromocytoma and paraganglioma: an endocrine society clinical practice guideline
Lenders, J. W. M., Duh, Q.-Y., Eisenhofer, G., Gimenez-Roqueplo, A.-P., Grebe, S. K. G., Murad, M. H., Naruse, M., Pacak, K., & Young, W. F. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-1498 · Cited by 2,827
Self-citationACMG recommendations for reporting of incidental findings in clinical exome and genome sequencing
Green, R. C., Berg, J. S., Grody, W. W., Kalia, S. S., Korf, B. R., Martin, C. L., McGuire, A. L., Nussbaum, R. L., O’Daniel, J. M., Ormond, K. E., et al. (2013) · Genetics in Medicine · doi:10.1038/gim.2013.73 · Cited by 2,541
Clinical Whole-Exome Sequencing for the Diagnosis of Mendelian Disorders
Yang, Y., Muzny, D. M., Reid, J. G., Bainbridge, M. N., Willis, A., Ward, P. A., Braxton, A., Beuten, J., Xia, F., Niu, Z., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1306555 · Cited by 1,964
Exome sequencing as a tool for Mendelian disease gene discovery
Bamshad, M. J., Ng, S. B., Bigham, A. W., Tabor, H. K., Emond, M. J., Nickerson, D. A., & Shendure, J. (2011) · Nature Reviews Genetics · doi:10.1038/nrg3031 · Cited by 1,673
The Multiple Leiomyoma Consortium (2002) · Nature Genetics · doi:10.1038/ng849 · Cited by 1,635
Repetitive DNA and next-generation sequencing: computational challenges and solutions
Treangen, T. J., & Salzberg, S. L. (2012) · Nature Reviews Genetics · doi:10.1038/nrg3117 · Cited by 1,597
Schmidt, L., Duh, F.-M., Chen, F., Kishida, T., Glenn, G., Choyke, P., Scherer, S. W., Zhuang, Z., Lubensky, I., Dean, M., et al. (1997) · Nature Genetics · doi:10.1038/ng0597-68 · Cited by 1,524
Advances in understanding cancer genomes through second-generation sequencing
Meyerson, M., Gabriel, S., & Getz, G. (2010) · Nature Reviews Genetics · doi:10.1038/nrg2841 · Cited by 1,116
LOVD v.2.0: the next generation in gene variant databases
Fokkema, I. F. A. C., Taschner, P. E. M., Schaafsma, G. C. P., Celli, J., Laros, J. F. J., & den Dunnen, J. T. (2011) · Human Mutation · doi:10.1002/humu.21438 · Cited by 1,048
Plon, S. E., Eccles, D. M., Easton, D., Foulkes, W. D., Genuardi, M., Greenblatt, M. S., Hogervorst, F. B. L., Hoogerbrugge, N., Spurdle, A. B., Tavtigian, S. V., et al. (2008) · Human Mutation · doi:10.1002/humu.20880 · Cited by 912
ACMG clinical laboratory standards for next-generation sequencing
Rehm, H. L., Bale, S. J., Bayrak-Toydemir, P., Berg, J. S., Brown, K. K., Deignan, J. L., Friez, M. J., Funke, B. H., Hegde, M. R., & Lyon, E. (2013) · Genetics in Medicine · doi:10.1038/gim.2013.92 · Cited by 907
Richards, C. S., Bale, S., Bellissimo, D. B., Das, S., Grody, W. W., Hegde, M. R., Lyon, E., & Ward, B. E. (2008) · Genetics in Medicine · doi:10.1097/gim.0b013e31816b5cae · Cited by 832
SDH mutations establish a hypermethylator phenotype in paraganglioma
Letouzé, E., Martinelli, C., Loriot, C., Burnichon, N., Abermil, N., Ottolenghi, C., Janin, M., Menara, M., Nguyen, A. T., Benit, P., et al. (2013) · Cancer Cell · doi:10.1016/j.ccr.2013.04.018 · Cited by 776
Self-citationGenetic Testing in Pheochromocytoma or Functional Paraganglioma
Amar, L., Bertherat, J., Baudin, E., Ajzenberg, C., Bressac-de Paillerets, B., Chabre, O., Chamontin, B., Delemer, B., Giraud, S., Murat, A., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.03.1484 · Cited by 684
Self-citationSDHA is a tumor suppressor gene causing paraganglioma
Burnichon, N., Brière, J.-J., Libé, R., Vescovo, L., Rivière, J., Tissier, F., Jouanno, E., Jeunemaitre, X., Bénit, P., Tzagoloff, A., et al. (2010) · Human Molecular Genetics · doi:10.1093/hmg/ddq206 · Cited by 650
Self-citationRealizing the promise of cancer predisposition genes
Rahman, N. (2014) · Nature · doi:10.1038/nature12981 · Cited by 624
Mutations in the SDHB gene are associated with extra-adrenal and/or malignant phaeochromocytomas.
Gimenez‐Roqueplo, A., Favier, J., Rustin, P., Rieubland, C., Crespin, M., Nau, V., Kien, P. K. V., Corvol, P. L., Plouin, P., & Jeunemaître, X. (2003) · PubMed · Cited by 547
Self-citationPheochromocytoma and paraganglioma pathogenesis: learning from genetic heterogeneity
Dahia, P. L. M. (2014) · Nature Reviews Cancer · doi:10.1038/nrc3648 · Cited by 545
Self-citationvan Nederveen, F. H., Gaal, J., Favier, J., Korpershoek, E., Oldenburg, R. A., de Bruyn, E. M., Sleddens, H. F., Derkx, P., Rivière, J., Dannenberg, H., et al. (2009) · The Lancet Oncology · doi:10.1016/s1470-2045(09)70164-0 · Cited by 538
Self-citationExome sequencing identifies MAX mutations as a cause of hereditary pheochromocytoma
Comino-Méndez, I., Gracia-Aznárez, F. J., Schiavi, F., Landa, I., Leandro-García, L. J., Letón, R., Honrado, E., Ramos-Medina, R., Caronia, D., Pita, G., et al. (2011) · Nature Genetics · doi:10.1038/ng.861 · Cited by 526
Self-citationGenenames.org: the HGNC resources in 2015
Gray, K. A., Yates, B., Seal, R. L., Wright, M. W., & Bruford, E. A. (2015) · Nucleic Acids Research · doi:10.1093/nar/gku1071 · Cited by 492
Paraganglioma and phaeochromocytoma: from genetics to personalized medicine
Favier, J., Amar, L., & Gimenez-Roqueplo, A.-P. (2015) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2014.188 · Cited by 490
Self-citationWalsh, T., Lee, M. K., Casadei, S., Thornton, A. M., Stray, S. M., Pennil, C., Nord, A. S., Mandell, J. B., Swisher, E. M., & King, M.-C. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1007983107 · Cited by 487
A HIF1α Regulatory Loop Links Hypoxia and Mitochondrial Signals in Pheochromocytomas
Dahia, P. L. M., Ross, K. N., Wright, M. E., Hayashida, C. Y., Santagata, S., Barontini, M., Kung, A. L., Sanso, G., Powers, J. F., Tischler, A. S., et al. (2005) · PLoS Genetics · doi:10.1371/journal.pgen.0010008 · Cited by 443
Self-citationSomatic HIF2A Gain-of-Function Mutations in Paraganglioma with Polycythemia
Zhuang, Z., Yang, C., Lorenzo, F., Merino, M., Fojo, T., Kebebew, E., Popovic, V., Stratakis, C. A., Prchal, J. T., & Pacak, K. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1205119 · Cited by 397
Germline mutations in FH confer predisposition to malignant pheochromocytomas and paragangliomas
Castro-Vega, L. J., Buffet, A., De Cubas, A. A., Cascón, A., Menara, M., Khalifa, E., Amar, L., Azriel, S., Bourdeau, I., Chabre, O., et al. (2014) · Human Molecular Genetics · doi:10.1093/hmg/ddt639 · Cited by 397
Self-citationVanharanta, S., Buchta, M., McWhinney, S. R., Virta, S. K., Peçzkowska, M., Morrison, C. D., Lehtonen, R., Januszewicz, A., Järvinen, H., Juhola, M., et al. (2004) · The American Journal of Human Genetics · doi:10.1086/381054 · Cited by 389
Burnichon, N., Rohmer, V., Amar, L., Herman, P., Leboulleux, S., Darrouzet, V., Niccoli, P., Gaillard, D., Chabrier, G., Chabolle, F., et al. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-2504 · Cited by 378
Self-citationGimenez-Roqueplo, A.-P., Favier, J., Rustin, P., Mourad, J.-J., Plouin, P.-F., Corvol, P., Rötig, A., & Jeunemaitre, X. (2001) · The American Journal of Human Genetics · doi:10.1086/324413 · Cited by 364
Self-citationGenetics and clinical characteristics of hereditary pheochromocytomas and paragangliomas
Welander, J., Söderkvist, P., & Gimm, O. (2011) · Endocrine-Related Cancer · doi:10.1530/erc-11-0170 · Cited by 355
Self-citationMutation and cancer: neuroblastoma and pheochromocytoma.
Knudson, A. G., & Strong, L. C. (1972) · PubMed · Cited by 341
Ricketts, C. J., Forman, J. R., Rattenberry, E., Bradshaw, N., Lalloo, F., Izatt, L., Cole, T. R., Armstrong, R., Kumar, V. K. A., Morrison, P. J., et al. (2010) · Human Mutation · doi:10.1002/humu.21136 · Cited by 337
Self-citationSchlisio, S., Kenchappa, R. S., Vredeveld, L. C. W., George, R. E., Stewart, R., Greulich, H., Shahriari, K., Nguyen, N. V., Pigny, P., Dahia, P. L., et al. (2008) · Genes & Development · doi:10.1101/gad.1648608 · Cited by 333
Self-citationMAX Mutations Cause Hereditary and Sporadic Pheochromocytoma and Paraganglioma
Burnichon, N., Cascón, A., Schiavi, F., Morales, N. P., Comino-Méndez, I., Abermil, N., Inglada-Pérez, L., de Cubas, A. A., Amar, L., Barontini, M., et al. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-0160 · Cited by 331
Self-citationPHD2 Mutation and Congenital Erythrocytosis with Paraganglioma
Ladroue, C., Carcenac, R., Leporrier, M., Gad, S., Le Hello, C., Galateau-Salle, F., Feunteun, J., Pouysségur, J., Richard, S., & Gardie, B. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0806277 · Cited by 323
Integrative genomic analysis reveals somatic mutations in pheochromocytoma and paraganglioma
Burnichon, N., Vescovo, L., Amar, L., Libé, R., de Reynies, A., Venisse, A., Jouanno, E., Laurendeau, I., Parfait, B., Bertherat, J., et al. (2011) · Human Molecular Genetics · doi:10.1093/hmg/ddr324 · Cited by 309
Self-citationMannelli, M., Castellano, M., Schiavi, F., Filetti, S., Giacchè, M., Mori, L., Pignataro, V., Bernini, G., Giachè, V., Bacca, A., et al. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-2419 · Cited by 303
Self-citationSalipante, S. J., Kawashima, T., Rosenthal, C., Hoogestraat, D. R., Cummings, L. A., Sengupta, D. J., Harkins, T. T., Cookson, B. T., & Hoffman, N. G. (2014) · Applied and Environmental Microbiology · doi:10.1128/aem.02206-14 · Cited by 301
Korpershoek, E., Favier, J., Gaal, J., Burnichon, N., van Gessel, B., Oudijk, L., Badoual, C., Gadessaud, N., Venisse, A., Bayley, J.-P., et al. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-1043 · Cited by 277
Self-citationSDHAF2 mutations in familial and sporadic paraganglioma and phaeochromocytoma
Bayley, J.-P., Kunst, H. P., Cascon, A., Sampietro, M. L., Gaal, J., Korpershoek, E., Hinojar-Gutierrez, A., Timmers, H. J., Hoefsloot, L. H., Hermsen, M. A., et al. (2010) · The Lancet Oncology · doi:10.1016/s1470-2045(10)70007-3 · Cited by 276
Self-citationPapathomas, T. G., Oudijk, L., Persu, A., Gill, A. J., van Nederveen, F., Tischler, A. S., Tissier, F., Volante, M., Matias-Guiu, X., Smid, M., et al. (2015) · Modern Pathology · doi:10.1038/modpathol.2015.41 · Cited by 227
Self-citationFamilial Gastrointestinal Stromal Tumors and Germ-Line Mutations
McWhinney, S. R., Pasini, B., & Stratakis, C. A. (2007) · New England Journal of Medicine · doi:10.1056/nejmc071191 · Cited by 224
Ayala-Ramirez, M., Chougnet, C. N., Habra, M. A., Palmer, J. L., Leboulleux, S., Cabanillas, M. E., Caramella, C., Anderson, P., Al Ghuzlan, A., Waguespack, S. G., et al. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-2356 · Cited by 212
Hadoux, J., Favier, J., Scoazec, J., Leboulleux, S., Al Ghuzlan, A., Caramella, C., Déandreis, D., Borget, I., Loriot, C., Chougnet, C., et al. (2014) · International Journal of Cancer · doi:10.1002/ijc.28913 · Cited by 210
Self-citationSpectrum and Prevalence of FP/TMEM127 Gene Mutations in Pheochromocytomas and Paragangliomas
Yao, L., Schiavi, F., Cascon, A., Qin, Y., Inglada-Pérez, L., King, E. E., Toledo, R. A., Ercolino, T., Rapizzi, E., Ricketts, C. J., et al. (2010) · JAMA · doi:10.1001/jama.2010.1830 · Cited by 202
Self-citation15 YEARS OF PARAGANGLIOMA: Clinical manifestations of paraganglioma syndromes types 1–5
Benn, D. E., Robinson, B. G., & Clifton-Bligh, R. J. (2015) · Endocrine-Related Cancer · doi:10.1530/erc-15-0268 · Cited by 197
Self-citationMulti-omics analysis defines core genomic alterations in pheochromocytomas and paragangliomas
Castro-Vega, L. J., Letouzé, E., Burnichon, N., Buffet, A., Disderot, P.-H., Khalifa, E., Loriot, C., Elarouci, N., Morin, A., Menara, M., et al. (2015) · Nature Communications · doi:10.1038/ncomms7044 · Cited by 196
Self-citationRecurrent epimutation of SDHC in gastrointestinal stromal tumors
Killian, J. K., Miettinen, M., Walker, R. L., Wang, Y., Zhu, Y. J., Waterfall, J. J., Noyes, N., Retnakumar, P., Yang, Z., Smith, W. I., et al. (2014) · Science Translational Medicine · doi:10.1126/scitranslmed.3009961 · Cited by 193
Whole-Exome Sequencing Identifies MDH2 as a New Familial Paraganglioma Gene
Cascón, A., Comino-Méndez, I., Currás-Freixes, M., de Cubas, A. A., Contreras, L., Richter, S., Peitzsch, M., Mancikova, V., Inglada-Pérez, L., Pérez-Barrios, A., et al. (2015) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djv053 · Cited by 192
Self-citationWhole-exome sequencing identifies somatic ATRX mutations in pheochromocytomas and paragangliomas
Fishbein, L., Khare, S., Wubbenhorst, B., DeSloover, D., D’Andrea, K., Merrill, S., Cho, N. W., Greenberg, R. A., Else, T., Montone, K., et al. (2015) · Nature Communications · doi:10.1038/ncomms7140 · Cited by 185
Hadd, A. G., Houghton, J., Choudhary, A., Sah, S., Chen, L., Marko, A. C., Sanford, T., Buddavarapu, K., Krosting, J., Garmire, L., et al. (2013) · The Journal of Molecular Diagnostics · doi:10.1016/j.jmoldx.2012.11.006 · Cited by 185
Germline FH Mutations Presenting With Pheochromocytoma
Clark, G. R., Sciacovelli, M., Gaude, E., Walsh, D. M., Kirby, G., Simpson, M. A., Trembath, R. C., Berg, J. N., Woodward, E. R., Kinning, E., et al. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-1659 · Cited by 177
Self-citationMu, W., Lu, H.-M., Chen, J., Li, S., & Elliott, A. M. (2016) · The Journal of Molecular Diagnostics · doi:10.1016/j.jmoldx.2016.07.006 · Cited by 176
Clinical Predictors and Algorithm for the Genetic Diagnosis of Pheochromocytoma Patients
Erlic, Z., Rybicki, L., Peczkowska, M., Golcher, H., Kann, P. H., Brauckhoff, M., Müssig, K., Muresan, M., Schäffler, A., Reisch, N., et al. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-1237 · Cited by 175
Self-citationWelander, J., Andreasson, A., Juhlin, C. C., Wiseman, R. W., Bäckdahl, M., Höög, A., Larsson, C., Gimm, O., & Söderkvist, P. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-4375 · Cited by 173
Self-citationComino-Méndez, I., de Cubas, A. A., Bernal, C., Álvarez-Escolá, C., Sánchez-Malo, C., Ramírez-Tortosa, C. L., Pedrinaci, S., Rapizzi, E., Ercolino, T., Bernini, G., et al. (2013) · Human Molecular Genetics · doi:10.1093/hmg/ddt069 · Cited by 169
Self-citationCrona, J., Verdugo, A. D., Maharjan, R., Stalberg, P. L. H., Granberg, D. O., Hellman, P., & Björklund, P. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-4257 · Cited by 160
Somatic NF1 inactivation is a frequent event in sporadic pheochromocytoma
Burnichon, N., Buffet, A., Parfait, B., Letouzé, É., Laurendeau, I., Loriot, C., Pasmant, É., Abermil, N., Valeyrie‐Allanore, L., Bertherat, J. Y., et al. (2012) · Human Molecular Genetics · doi:10.1093/hmg/dds374 · Cited by 159
Self-citationYang, C., Zhuang, Z., Fliedner, S. M. J., Shankavaram, U. T., Sun, M. G., Bullova, P., Zhu, R., ELKAHLOUN, A. G., Kourlas, P. J., Merino, M. J., et al. (2014) · Journal of Molecular Medicine · doi:10.1007/s00109-014-1205-7 · Cited by 153
Toledo, R. A., Qin, Y., Cheng, Z.-M., Gao, Q., Iwata, S., Silva, G. M., Prasad, M. L., Ocal, I. T., Rao, S. N., D, N. A. M., et al. (2015) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-15-1841 · Cited by 153
Self-citationA germline mutation of the KIF1Bβ gene on 1p36 in a family with neural and nonneural tumors
Yeh, I., Lenci, R., Qin, Y., Buddavarapu, K., Ligon, A. H., Leteurtre, E., Cao, C. D., Cardot-Bauters, C., Pigny, P., & Dahia, P. L. M. (2008) · Human Genetics · doi:10.1007/s00439-008-0553-1 · Cited by 149
Self-citationNew syndrome of paraganglioma and somatostatinoma associated with polycythemia.
Pacak, K., Jochmanová, I., Prodanov, T., Yang, C.-Z., Merino, M., Fojo, T., Prchal, J., Tischler, A., Lechan, R., & Zhuang, Z. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2012.47.1912 · Cited by 148
Currás-Freixes, M., Inglada‐Pérez, L., Mančíková, V., Montero‐Conde, C., Letón, R., Comino‐Méndez, I., Apellániz-Ruiz, M., Sánchez, L. M. M., Sánchez-Covisa, M. A., Alcázar, V., et al. (2015) · Journal of Medical Genetics · doi:10.1136/jmedgenet-2015-103218 · Cited by 138
Self-citationIn vivo and in vitro oncogenic effects of HIF2A mutations in pheochromocytomas and paragangliomas
Toledo, R. A., Qin, Y., Srikantan, S., Morales, N. P., Li, Q., Deng, Y., Kim, S.-W., Pereira, M. A. A., Toledo, S. P. A., Su, X., et al. (2013) · Endocrine Related Cancer · doi:10.1530/erc-13-0101 · Cited by 136
Self-citationIsocitrate Dehydrogenase Mutations Are Rare in Pheochromocytomas and Paragangliomas
Gaal, J., Burnichon, N., Korpershoek, E., Roncelin, I., Bertherat, J. Y., Plouin, P., de Krijger, R. R., Gimenez‐Roqueplo, A., & Dinjens, W. N. M. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-2170 · Cited by 131
Self-citationClaustres, M., Kožich, V., Dequeker, E., et al. (2013) · European Journal of Human Genetics · doi:10.1038/ejhg.2013.125 · Cited by 126
Metastatic Pheochromocytoma and Paraganglioma: Focus on Therapeutics
Plouin, P., Fitzgerald, P., Rich, T. A., Ayala‐Ramirez, M., Perrier, N. D., Baudin, É., & Jiménez, C. (2012) · Hormone and Metabolic Research · doi:10.1055/s-0031-1299707 · Cited by 125
SDHB-Deficient Cancers: The Role of Mutations That Impair Iron Sulfur Cluster Delivery
Saxena, N., Maio, N., Crooks, D. R., Ricketts, C. J., Yang, Y., Wei, M.-H., Fan, T. W. ‐., Lane, A. N., Sourbier, C., Singh, A., et al. (2015) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djv287 · Cited by 125
Quality control in molecular genetic testing
Dequeker, E. M. C., Ramsden, S., Grody, W. W., Stenzel, T. T., & Barton, D. E. (2001) · Nature Reviews Genetics · doi:10.1038/35088588 · Cited by 119
A Decade (2001-2010) of Genetic Testing for Pheochromocytoma and Paraganglioma
Buffet, A., Vénisse, A., Nau, V., Roncelin, I., Boccio, V., Pottier, N. L., Boussion, M., Travers, C., Simian, C., Burnichon, N., et al. (2012) · Hormone and Metabolic Research · doi:10.1055/s-0032-1304594 · Cited by 119
Self-citationIntegrative genomics reveals frequent somatic NF1 mutations in sporadic pheochromocytomas
Welander, J., Larsson, C., Bäckdahl, M., Hareni, N., Sivlér, T., Brauckhoff, M., Söderkvist, P., & Gimm, O. (2012) · Human Molecular Genetics · doi:10.1093/hmg/dds402 · Cited by 119
Self-citationFamilial SDHA Mutation Associated With Pituitary Adenoma and Pheochromocytoma/Paraganglioma
Dwight, T., Mann, K., Benn, D. E., Robinson, B. G., McKelvie, P. A., Gill, A. J., Winship, I., & Clifton-Bligh, R. J. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-1400 · Cited by 118
Self-citationMosaicism inHIF2A-Related Polycythemia-Paraganglioma Syndrome
Buffet, A., Smati, S., Mansuy, L., Menara, M., Bras, M. L., Heymann, M., Simian, C., Favier, J., Murat, A., Cariou, B., et al. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-2600 · Cited by 105
Self-citationRattenberry, E., Vialard, L., Yeung, A. C. Y., Bair, H., McKay, K., Jafri, M., Canham, N. L. E., Cole, T. R. P., Dénes, J., Hodgson, S. V., et al. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-1319 · Cited by 105
Self-citationXekouki, P., & Stratakis, C. A. (2012) · Endocrine Related Cancer · doi:10.1530/erc-12-0118 · Cited by 100
267 Spanish Exomes Reveal Population-Specific Differences in Disease-Related Genetic Variation
Dopazo, J., Amadoz, A., Bleda, M., García‐Alonso, L., Alemán, A., Garcia‐García, F., Rodríguez, J. A., Daub, J. T., Muntané, G., Rueda, A., et al. (2016) · Molecular Biology and Evolution · doi:10.1093/molbev/msw005 · Cited by 100
Luchetti, A., Walsh, D. M., Rodger, F., Clark, G. R., Martin, T., Irving, R. M., Sanna, M., Yao, M., Robledo, M., Neumann, H. P. H., et al. (2015) · International Journal of Endocrinology · doi:10.1155/2015/138573 · Cited by 94
Self-citationMcWhinney, S. R., Pilarski, R. T., Forrester, S. R., Schneider, M. C., Sarquis, M. M., Dias, E. P., & Eng, C. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-0769 · Cited by 89
Genetic testing and quality control in diagnostic laboratories
Dequeker, E. M. C., & Cassiman, J. (2000) · Nature Genetics · doi:10.1038/77008 · Cited by 89
The genomic landscape of phaeochromocytoma
Flynn, A., Benn, D. E., Clifton-Bligh, R. J., Robinson, B. G., Trainer, A. H., James, P. A., Hogg, A., Waldeck, K., George, J., Li, J., et al. (2014) · The Journal of Pathology · doi:10.1002/path.4503 · Cited by 83
Self-citationLussey‐Lepoutre, C., Bellucci, A., Morin, A., Buffet, A., Amar, L., Janin, M., Ottolenghi, C., Zinzindohoué, F., Autret, G., Burnichon, N., et al. (2015) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-15-1576 · Cited by 83
Self-citationFrequent EPAS1/HIF2α exons 9 and 12 mutations in non-familial pheochromocytoma
Welander, J., Stenman, A., Brauckhoff, M., Bäckdahl, M., Larsson, C., Gimm, O., & Söderkvist, P. (2014) · Endocrine Related Cancer · doi:10.1530/erc-13-0384 · Cited by 82
Self-citationHead and neck paragangliomas: genetic spectrum and clinical variability in 79 consecutive patients
Piccini, V., Rapizzi, E., Bacca, A., Trapani, G. D., Pulli, R., Giaché, V., Zampetti, B., Cordisco, E. L., Canu, L., Corsini, E., et al. (2012) · Endocrine Related Cancer · doi:10.1530/erc-11-0369 · Cited by 78
Self-citationImpériale, A., Moussallieh, F., Roche, P., Battini, S., Çiçek, A. E., Sebag, F. A., Brunaud, L., Barlier, A., Elbayed, K., Loundou, A., et al. (2015) · Neoplasia · doi:10.1016/j.neo.2014.10.010 · Cited by 77
de Cubas, A. A., Korpershoek, E., Inglada‐Pérez, L., Letouzé, É., Currás-Freixes, M., Fernández, A. F., Comino‐Méndez, I., Schiavi, F., Mančíková, V., Eisenhofer, G., et al. (2015) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-14-2804 · Cited by 76
Self-citationGross SDHB deletions in patients with paraganglioma detected by multiplex PCR: A possible hot spot?
Cascón, A., Montero‐Conde, C., Ruiz‐Llorente, S., Mercadillo, F., Letón, R., Rodríguez‐Antona, C., Martínez–Delgado, B., Delgado, M., Díez, A., Rovira, A., et al. (2005) · Genes Chromosomes and Cancer · doi:10.1002/gcc.20283 · Cited by 75
Self-citationHIF2A mutations in paraganglioma with polycythemia.
Favier, J., Buffet, A., & Gimenez-Roqueplo, A. (2012) · New England Journal of Medicine · doi:10.1056/nejmc1211953 · Cited by 73
Self-citationSomatic mosaicism in von Hippel-Lindau disease
Murgia, A., Martella, M., Vinanzi, C., Polli, R., Perilongo, G., & Opocher, G. (2000) · Human Mutation · doi:10.1002/(sici)1098-1004(200001)15:1<114::aid-humu20>3.0.co;2-7 · Cited by 73
Self-citationJuhlin, C. C., Stenman, A., Haglund, F., Clark, V. E., Brown, T. C., Baranoski, J. F., Bilgüvar, K., Goh, G., Welander, J., Svahn, F., et al. (2015) · Genes Chromosomes and Cancer · doi:10.1002/gcc.22267 · Cited by 69
Self-citationReporting genomic secondary findings: ACMG members weigh in
Scheuner, M. T., Peredo, J., Benkendorf, J., Bowdish, B. E., Feldman, G. L., Fleisher, L. D., Mulvihill, J. J., Watson, M. S., Herman, G. E., & Evans, J. P. (2014) · Genetics in Medicine · doi:10.1038/gim.2014.165 · Cited by 67
Precision medicine in pheochromocytoma and paraganglioma: current and future concepts
Björklund, P., Pacák, K., & Crona, J. (2016) · Journal of Internal Medicine · doi:10.1111/joim.12507 · Cited by 67
A Standardized DNA Variant Scoring System for Pathogenicity Assessments in Mendelian Disorders
Karbassi, I., Maston, G. A., Love, A., Divincenzo, C., Braastad, C. D., Elzinga, C. D., Bright, A. R., Previte, D., Zhang, K., Rowland, C., et al. (2015) · Human Mutation · doi:10.1002/humu.22918 · Cited by 66
Qin, Y., Deng, Y., Ricketts, C. J., Srikantan, S., Wang, E., Maher, E. R., & Dahia, P. L. M. (2013) · Human Molecular Genetics · doi:10.1093/hmg/ddt638 · Cited by 65
Self-citationKorpershoek, E., Koffy, D., Eussen, B. H. J., Oudijk, L., Papathomas, T. G., van Nederveen, F. H., Belt, E. J. T., Franssen, G. J. H., Restuccia, D. F., Krol, N. M. G., et al. (2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2015-2592 · Cited by 64
Baysal, B. E., & Maher, E. R. (2015) · Endocrine Related Cancer · doi:10.1530/erc-15-0226 · Cited by 62
Self-citationBourgon, R., Lu, S., Yan, Y., Lackner, M. R., Wang, W., Weigman, V., Wang, D., Guan, Y., Ryner, L. C., Koeppen, H., et al. (2014) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-13-3114 · Cited by 61
Whole-Exome sequencing identifies novelLEPRmutations in individuals with severe early onset obesity
Gill, R. J., Cheung, Y. H., Shen, Y., Lanzano, P., Mirza, N. M., Ten, S., Maclaren, N. K., Motaghedi, R., Han, J. C., Yanovski, J. A., et al. (2013) · Obesity · doi:10.1002/oby.20492 · Cited by 57
Oudijk, L., de Krijger, R. R., Rapa, I., Beuschlein, F., de Cubas, A. A., Tos, A. P. D., Dinjens, W. N. M., Korpershoek, E., Mančíková, V., Mannelli, M., et al. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-3879 · Cited by 56
Self-citationSDHD Immunohistochemistry: A New Tool to ValidateSDHxMutations in Pheochromocytoma/Paraganglioma
Menara, M., Oudijk, L., Badoual, C., Bertherat, J. Y., Lussey‐Lepoutre, C., Amar, L., Iturrioz, X., Sibony, M., Zinzindohoué, F., de Krijger, R. R., et al. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-1870 · Cited by 55
Self-citationBiological data sciences in genome researchPreprint
Schatz, M. C. (2015) · Genome Research · doi:10.1101/gr.191684.115 · Cited by 54
Epigenetic Mutation of the Succinate Dehydrogenase C Promoter in a Patient With Two Paragangliomas
Richter, S., Klink, B., Nacke, B., de Cubas, A. A., Mangelis, A., Rapizzi, E., Meinhardt, M., Skondra, C. D., Mannelli, M., Robledo, M., et al. (2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2015-3856 · Cited by 53
Self-citationMonozygotic twins discordant for neurofibromatosis 1
Kaplan, L. M., Foster, R., Shen, Y., Parry, D. M., McMaster, M. L., O’Leary, M., & Gusella, J. F. (2010) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.33271 · Cited by 48
Hernandez, K., Ezzat, S., Morel, C. F., Swallow, C. J., Otremba, M., Dickson, B. C., Asa, S. L., & Mete, Ö. (2015) · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · doi:10.1007/s00428-015-1755-2 · Cited by 46
A novel TMEM127 mutation in a patient with familial bilateral pheochromocytoma
Burnichon, N., Lussey‐Lepoutre, C., Laffaire, J., Gadessaud, N., Molinié, V., Hernigou, A., Plouin, P., Jeunemaître, X., Favier, J., & Gimenez‐Roqueplo, A. (2010) · European Journal of Endocrinology · doi:10.1530/eje-10-0758 · Cited by 46
Self-citationCrona, J., Verdugo, A. D., Granberg, D. O., Welin, S., Stalberg, P. L. H., Hellman, P., & Björklund, P. (2013) · Endocrine Connections · doi:10.1530/ec-13-0009 · Cited by 42
McInerney-Leo, A. M., Marshall, M. S., Gardiner, B., Benn, D. E., McFarlane, J., Robinson, B. G., Brown, M. A., Leo, P. J., Clifton-Bligh, R. J., & Duncan, E. L. (2013) · Clinical Endocrinology · doi:10.1111/cen.12331 · Cited by 39
Self-citationStructural and functional consequences of succinate dehydrogenase subunit B mutations
Kim, E., Rath, E. M., Tsang, V., Duff, A. P., Robinson, B. G., Church, W. B., Benn, D. E., Dwight, T., & Clifton-Bligh, R. J. (2015) · Endocrine Related Cancer · doi:10.1530/erc-15-0099 · Cited by 39
Self-citationGenetics of Familial Renal Cancers
Maher, E. R. (2010) · Nephron Experimental Nephrology · doi:10.1159/000320892 · Cited by 35
Self-citationTack, V., Deans, Z. C., Wolstenholme, N., Patton, S. J., & Dequeker, E. M. C. (2016) · Human Mutation · doi:10.1002/humu.22975 · Cited by 31
Functional and in silico assessment of MAX variants of unknown significance
Comino‐Méndez, I., Leandro-Garcia, L. J., Montoya, G., Inglada‐Pérez, L., de Cubas, A. A., Currás-Freixes, M., Tysoe, C. J., Izatt, L., Letón, R., Gómez-Graña, Á., et al. (2015) · Journal of Molecular Medicine · doi:10.1007/s00109-015-1306-y · Cited by 29
Self-citationCarney triad, SDH-deficient tumors, and Sdhb+/− mice share abnormal mitochondria
Szarek, E., Ball, E. R., Impériale, A., Tsokos, M., Faucz, F. R., Giubellino, A., Moussallieh, F., Namer, I. J., Abu-Asab, M. S., Pacák, K., et al. (2015) · Endocrine Related Cancer · doi:10.1530/erc-15-0069 · Cited by 29
Sequence Variants of Uncertain Significance
Greenblatt, M. S. (2015) · Surgical Oncology Clinics of North America · doi:10.1016/j.soc.2015.06.009 · Cited by 11
King, E. E., Qin, Y., Toledo, R. A., Luo, A., Ball, E. H., Faucz, F. R., Janeway, K. A., Stratakis, C. A., Tomlinson, G. E., & Dahia, P. L. M. (2015) · Endocrine Related Cancer · doi:10.1530/erc-15-0101 · Cited by 6
Self-citation
Cited by
2018 ESC/ESH Guidelines for the management of arterial hypertension
Williams, B., Mancia, G., Spiering, W., Agabiti Rosei, E., Azizi, M., Burnier, M., Clement, D. L., Coca, A., de Simone, G., Dominiczak, A., et al. (2018) · European Heart Journal · doi:10.1093/eurheartj/ehy339 · Cited by 10,286
Williams, B., Mancia, G., Spiering, W., Agabiti Rosei, E., Azizi, M., Burnier, M., Clement, D. L., Coca, A., de Simone, G., Dominiczak, A., et al. (2018) · Journal of Hypertension · doi:10.1097/hjh.0000000000001940 · Cited by 2,885
Overview of the 2017 WHO Classification of Pituitary Tumors
Mete, O., & Lopes, M. B. (2017) · Endocrine Pathology · doi:10.1007/s12022-017-9498-z · Cited by 460
Fassnacht, M., Assie, G., Baudin, E., Eisenhofer, G., de la Fouchardiere, C., Haak, H. R., de Krijger, R., Porpiglia, F., Terzolo, M., & Berruti, A. (2020) · Annals of Oncology · doi:10.1016/j.annonc.2020.08.2099 · Cited by 436
Lenders, J. W. M., Kerstens, M. N., Amar, L., Prejbisz, A., Robledo, M., Taieb, D., Pacak, K., Crona, J., Zelinka, T., Mannelli, M., et al. (2020) · Journal of Hypertension · doi:10.1097/hjh.0000000000002438 · Cited by 413
Self-citation
Metadata
- Authors
- The NGS in PPGL (NGSnPPGL) Study Group, Toledo, R. A., Burnichon, N., Cascon, A., Benn, D. E., Bayley, J.-P., Welander, J., Tops, C. M., Firth, H., Dwight, T., Ercolino, T., Mannelli, M., Opocher, G., Clifton-Bligh, R., Gimm, O., Maher, E. R., Robledo, M., Gimenez-Roqueplo, A.-P., & Dahia, P. L. M.
- Venue
- Nature Reviews Endocrinology
- Published
- 2016-11-18
- Volume
- 13
- Issue
- 4
- Pages
- 233-247
- ISSN
- 1759-5029 (ISSN-L)
- 1759-5037
- OpenAlex
- W2556416067
- Cited by
- 275
- References
- 117
- FWCI
- 6.75
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.